When combined with STING agonists, Rg3 can induce tumor-associated macrophages to polarize from M2 to M1 and improve the tumor microenvironment, effectively inhibiting the growth and invasion of triple-negative breast cancer (104). The gene discussed is STING1; the disease is neoplasm.